JWG-045

Overview

JWG-045 is a selective ERK5 inhibitor. JWG-045 exhibits unique ferroptosis -resistant activity independent of ERK5 inhibition. JWG-045 can be used in breast cancer research.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Breast Cancer | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > ERK | Products > Signaling Pathways > Ferroptosis

Product Information

• Catalog No.: HY-181968
• CAS No.: 1234480-61-5
• Molecular Formula: C27H33N7O2
• Molecular Weight: 487.60
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source